Docstoc
EXCLUSIVE OFFER FOR DOCSTOC USERS
Try the all-new QuickBooks Online for FREE.  No credit card required.

H2 2012 | Aarkstore.com || Respiratory Tract Inflammatory Disorders – Pipeline Review, H2 2012

Document Sample
H2 2012  | Aarkstore.com || Respiratory Tract Inflammatory Disorders – Pipeline Review, H2 2012 Powered By Docstoc
					You can also request for sample page of above
mention reports on sample@aarkstore.com
Pages : 127

PDF - $ 2500 | Site Licence - $ 5000 $ | Enterprise License - $
7500 |
Summary

Global Markets Direct’s, Respiratory Tract Inflammatory Disorders -
Pipeline Review, H2 2012, provides an overview of the indication’s
therapeutic pipeline. This report provides information on the therapeutic
development for Respiratory Tract Inflammatory Disorders, complete with
latest updates, and special features on late-stage and discontinued projects.
It also reviews key players involved in the therapeutic development for
Respiratory Tract Inflammatory Disorders. Respiratory Tract Inflammatory
Disorders - Pipeline Review, Half Year is built using data and information
sourced from Global Markets Direct’s proprietary databases,
Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific
third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on
the availability and relevance of data for the indicated disease.
Scope

- A snapshot of the global therapeutic scenario for Respiratory Tract
Inflammatory Disorders.
- A review of the Respiratory Tract Inflammatory Disorders products under
development by companies and universities/research institutes based on
information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under
development for Respiratory Tract Inflammatory Disorders.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most
promising pipeline.
Table of Contents :

List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Respiratory Tract Inflammatory Disorders Overview 8
Therapeutics Development 9
An Overview of Pipeline Products for Respiratory Tract Inflammatory
Disorders 9
Respiratory Tract Inflammatory Disorders Therapeutics under Development
by Companies 11
Respiratory Tract Inflammatory Disorders Therapeutics under Investigation
by Universities/Institutes 15
Late Stage Products 17
Comparative Analysis 17
Mid Clinical Stage Products 18
Comparative Analysis 18
Early Clinical Stage Products 19
Comparative Analysis 19
Discovery and Pre-Clinical Stage Products 20
Comparative Analysis 20……………..
Please follow link if you want More Related
Reports :


Pipeline Review, H2 2012

http://www.aarkstore.com/search/viewresults.asp?search=Pipeline
Review, H2 2012&PubId=&pagenum=1
Related Reports:

Generalized Seizures – Pipeline Review, H2 2012
Cataract – Pipeline Review, H2 2012
Hyperphosphatemia In Chronic Kidney Disease – Pipeline Review, H2 2012
Thrombocythaemia Myelofibrosis – Pipeline Review, H2 2012
Erosive Oral Lichen Planus – Pipeline Review, H2 2012
Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H2 2012
Blepharitis – Pipeline Review, H2 2012
Hypoparathyroidism – Pipeline Review, H2 2012
Lyme Disease – Pipeline Review, H2 2012
Optic Nerve Injury – Pipeline Review, H2 2012
Auto Inflammatory Disease – Pipeline Review, H2 2012
West Nile Virus Infections – Pipeline Review, H2 2012
Hypereosinophilic Syndrome – Pipeline Review, H2 2012
Gastroenteritis – Pipeline Review, H2 2012
Gingivitis – Pipeline Review, H2 2012
Bacteremia – Pipeline Review, H2 2012
Cellulite – Pipeline Review, H2 2012
Solid Tumor – Pipeline Review, H2 2012
Thrombocythaemia Myelofibrosis – Pipeline Review, H2 2012

Advanced Malignancy – Pipeline Review, H2 2012

Auto Inflammatory Disease – Pipeline Review, H2 2012

Hypereosinophilic Syndrome – Pipeline Review, H2 2012

Respiratory Tract Inflammatory Disorders – Pipeline Review, H2
2012
For More details about above & other
Reports plz contact :


Lavanya
Aarkstore.com

Contact: Marketing team Mob.No.918149852585
Email: enquiry@aarkstore.com ,
discount@aarkstore.com
URL: http://www.aarkstore.com
http://in.linkedin.com/in/aarkstore
http://www.facebook.com/aarkstore

				
DOCUMENT INFO
Shared By:
Stats:
views:2
posted:12/7/2012
language:
pages:9